印第安纳州医疗实践估值：从业者在出售给集团前应了解的事项

大多数医生开始时走错了方向。他们询问多个医疗实践的售价倍数，或者医院或私募股权支持的集团会支付多少收入百分比。这是可以理解的，但这并不是严肃买家在印第安纳州如何评估一个实践。他们并不购买你的总收费。他们不购买你自我安慰的忠诚传说。他们不购买仅仅因为你拥有这个地方并且工作比替代医生更努力而存在的收益版本。他们购买的是在提供者更替后、支付方摩擦后、合规审查后，以及员工和患者对新门牌名称作出反应后的持久现金流。.

这就是为什么医疗实践估值可以在不改变顶线的情况下移动七位数的原因。一个拥有有序收入周期、稳定雇佣医生、可辩护附属服务和干净租约的$6百万多提供者实践，可能会产生与一个由一个雨人控制推荐、90天应收账款堆积如山、每个重要关系仍然通过创始人的手机进行的$6百万实践截然不同的结果。.

印第安纳州的地理特征增添了另一层面。根据人口普查快速事实，哈密尔顿县截至2025年7月1日有387,036名居民，比2020年基数增加了11.4%，2020-2024年的家庭收入中位数为$121,530，2022年的医疗保健和社会援助收入为$3.65亿。马里昂县是规模市场，截至2025年7月1日有992,196名居民，2022年的医疗保健收入为$17.01亿，2023年有24,248个雇主单位。艾伦县为买家提供了强大的韦恩堡区域中心故事，居民人数为402,329，医疗保健收入为$6.23亿，雇主单位为9,696个。范德堡县在181,995名居民和$3.02亿的医疗保健收入中，仍然是印第安纳州南部一个重要的医疗市场。买家不会忽视这些事实。他们利用这些信息来决定你的未来增长是否可信。.

截至2026年4月11日，印第安纳州市场仍然对优质医生实践有真实需求，但这种需求是选择性的。医院系统很谨慎，因为医生薪酬、斯塔克法和服务地点策略都很重要。PE支持的团体也很谨慎，因为费率并不便宜，平台买家希望获得真正整合的附加服务，没有人想为当一位医生离开时消失的收入支付过高的费用。如果你想在测试市场之前有一个干净的起点，可以从一个开始。 专业评估.

大多数业主在首次收到兴趣信号之前会忽视的另一个要点是：企业价值与您所保留的并不相同。债务偿还、税收、营运资本预期、雇佣条款、滚动股权以及经纪人的成功费用都会改变实际结果。中西部商业经纪人在 $1 百万到 $10 百万的范围内工作，并使用双重利曼规模：在前 $1 百万上为 10%，第二个为 8%，第三个为 6%，第四个为 4%，以及在 $4 百万以上为 2%。严肃的卖家关心的是净收益和交易确定性，而不仅仅是头条数字.

本文的其余部分是买方的视角。不是一份通用的医疗咨询备忘录，也不是一篇合规论文。这是医院系统、PE支持的医疗集团、贷方和经验丰富的并购顾问在合格卖家试图退出到一个集团时，实际上如何为印第安纳州的医疗实践定价的.

2026 年印第安纳州医疗实践的实际销售价格

第一个诚实的答案是，印第安纳州的医疗实践并不是基于一个通用公式。较小的、以业主为中心的实践仍然以粗略的收入标准进行讨论，因为补偿是扭曲的，买家试图解决替代经济问题。拥有多个雇佣提供者、真实附属服务和可信管理深度的大型集团则根据调整后的EBITDA进行估值。从一个框架跳到另一个框架并不是表面上的变化。这是你的实践停止作为一个有 goodwill 的工作，而开始作为一个准备转让的运营业务的时刻.

这些不是公开交易的倍数，因为这个规模范围内的医生实践交易并不像大型股票那样公开报价。它们是基于真实买家和贷方如何解决可转移性的问题的市场范围。确切的数字存在于细节中。如果您的实践有两名在职医生在清晰的协议下，一支实际产生的护士执业者团队，以及支持收入的支付方合同，您将接近该范围的上半部分。如果一名医生产生了一半的EBITDA，并希望在交易关闭后的第二天退休，您将不会。.

县级需求影响这些范围，超过了业主们愿意承认的程度。汉密尔顿县为买家提供了增长故事、吸引力和商业支付深度。马里昂县提供规模、密度和大型医疗系统的足迹。艾伦县支持福特韦恩作为区域专业服务的中心。在增长较弱或较小的农村市场，买家仍会进行交易，但他们支付的是已证明的稳定性，而非预期的上升。这就是为什么一般 印第安纳州商业估值 框架在受监管的行业中仍然重要：市场总是在定价耐久性。.

融资也为个别买家和小型团体买家能支付的金额设定了底线，截至2026年4月11日，基准利率仍为6.75%，而大多数较大7(a)贷款的SBA最高浮动利率仍为9.75%。一笔270万美元的收购票据在9.75%的利率下，按10年摊销，每年的本金和利息约为423,696美元。在1.25倍的债务服务覆盖要求下，这意味着大约529,620美元的可靠替换后现金流，仅用于清除贷方的数学计算。即使你可能的买家是医院或PE支持的团体，这种融资背景也会影响更广泛市场的价值感。.

现在看看卖方的情况。$5.8百万的企业价值听起来很干净，但当你进行费用计算和结构计算时就会发现问题。在双雷曼规模下，中西部商业经纪人对$5.8百万的费用是$316,000：第一个百万$100,000，第二个百万$80,000，第三个百万$60,000，第四个百万$40,000，最后$1.8百万的费用是$36,000。如果交易还包括债务偿还、营运资金的真实调整和保留的股权部分，头条价值与实际流动性之间的差距会迅速扩大。理解这些的卖方在谈判中会更有优势.

医院系统与私募股权支持的集团：各自如何评估您的实践

业主们喜欢问医院还是私募股权支付更多。这是错误的第一个问题。正确的问题是哪种买家类型喜欢您拥有的确切实践，以及该买家如何表达价值。医院系统可能会对填补地理覆盖空白的初级护理组给出最高的现金到手数字。私募股权支持的平台可能会对具有可重复的EBITDA、附属业务和可以在一个地区扩展的提供者团队的专业实践给出最高的倍数。这些不是同一种实践，它们也不是同一种出价方式.

医院系统通常在考虑战略效用时，先于考虑纯粹的倍数。如果你的诊所帮助他们在一个县建立基础，保持入院和下游服务在网络内，或解决他们无法快速招聘的专业领域的准入问题，医院可以证明支付的不仅仅是过去的收益。这对卖方尤其有利，特别是在初级护理、心脏病学、骨科、妇女健康以及其他地理覆盖重要的专业领域。这也可能伴随着更严格的尽职调查、更慢的治理，以及对公平市场价值和补偿支持的更多关注.

PE支持的集团情感较少，更加公式化，这并不总是坏事。他们通常最关心的是在创始人依赖性被剔除后存活下来的标准化EBITDA，提供者名单在两年后的样子，平台是否能改善调度或收入周期，以及诊所是否填补了区域地图。如果你的团队有三名高产的雇佣医生、一位稳定的管理员、良好的报告和可重复的辅助组合，机构买家可能会表现得很积极，因为他们正在购买一个适合现有系统的单位.

卖家最大的错误是比较标题价值而不是经济现实。一家医院可能在交易时提供 $6.1 百万美元的现金，但将医生的雇佣套餐与保守的生产力假设挂钩。一家私募股权支持的集团可能提供 $6.5 百万美元，其中包括 70% 现金、20% 续约和 10% 与保留挂钩。哪个更好取决于卖家的目标、风险承受能力以及交易后计划的可信度。如果你仍然将所有者薪酬、个人福利和实际运营收益混为一谈，请阅读 SDE与EBITDA的解释 在你开始权衡意向书之前。.

这是一个简单的例子。假设一个四名提供者的专业实践产生 $1.2 百万美元的调整后 EBITDA。如果所有四名提供者都签有长期协议且附属服务干净，私募股权支持的集团可能会支付 6.25 倍，或 $7.5 百万美元。一家不需要该服务线或在该县已有覆盖的医院系统可能会接近 5.5 倍，或 $6.6 百万美元。翻转事实。假设该实践是低利润的初级护理，而医院在一个有接入问题的县希望停止下游转诊泄漏。医院现在可能是高价支付者，而私募股权则失去兴趣，因为利润故事很薄弱。这就是为什么“谁支付更多？”这个通用问题没有用。.

正确的预售工作是确定您的实践支持哪个买方论点，然后用该语言包装业务。战略买家希望获得访问权限、对齐和服务线逻辑。机构买家希望规模、可重复性和有文档记录的EBITDA。将这些故事混合在一起的卖家通常在两个受众中表现不佳。.

收入质量：支付者组合、收款和应收账款

收入质量是医生实践估值不再是虚荣练习而开始成为财务练习的地方。买家不关心您开具的账单，如果钱没有干净地进来。他们关心您收集的金额，这些收款的可预测性，您对某一支付者类别的暴露程度，索赔转化为现金的速度，以及买家在成交后需要做多少工作来修复这个周期。.

以两家印第安纳州的医疗机构为例，它们的总收费均为$6.2百万。A机构在52%商业、28%医疗保险、12%医疗补助和8%自付费用的付款组合中收集了$4.45百万。应收账款天数为38天，拒付情况得到控制，且仅有11%的应收款项超过90天。B机构在34%商业、24%医疗保险、30%医疗补助和12%自付费用的组合中收集了$3.96百万，应收账款天数为57天，且19%的应收款项超过90天。如果A机构产生了$930,000的调整后EBITDA，而B机构产生了$610,000，则5.5倍的倍数仅从收入质量来看就产生了$1.76百万的价值差距。收费相同，但价值却大相径庭.

这就是付款组合的重要性。商业收入并不总是优于其他收入，尤其是当合同较弱时，但通常它支持更强的报销概况和比偏向低支付的医疗补助或长期难以收回的自付费用更容易的承保。医疗保险具有可预测性，但并不总是有定价权。医疗补助在战略上可能很重要，特别是在儿科、家庭医学、行为健康和一些多专科环境中，但买方会在收入的基础上考虑运营负担。.

印第安纳州医疗补助增加了实际复杂性。印第安纳州健康覆盖计划表示，该州与六个管理医疗计划合作，涵盖HIP、Hoosier Care Connect、Hoosier Healthwise和PathWays，这些合作伙伴负责网络开发、合同和资质认证、索赔处理、使用管理和提供者外展。这意味着一个以医疗补助为主的实践不仅仅是在销售患者数量。它是在销售一个合同管理和资质认证的机器。如果您的员工无法展示低拒绝率、及时续约和严格的资格验证，买家会假设存在利润流失.

应收账款从不同角度讲述了同样的故事。医院系统通常将应收账款排除在企业价值倍数之外，并单独购买，或者他们建立一个营运资金基准，实际上迫使卖方将正常应收账款留在后面。私募股权支持的集团通常会进行更详细的账龄审查，并积极削减过时的余额。如果您的应收账款中有20%超过120天，买家不会为此支付全额倍数信用。他们要么会折扣营运资金假设，要么会基于您的账单操作高估可实现价值的理论，向下调整您的收入.

业主在收款比例分析上也变得懒惰。他们喜欢通过指向专业组合或“印第安纳州报销现实”来为弱的净收款辩护。严肃的买家不会轻易接受这一点。他们想要提供者级别的生产力、CPT组合、拒付趋势、注销政策，以及证据表明该诊所实际上是被管理而不是被容忍的。如果您打算出售，请在第一个买家询问之前将这些计划整理好。一旦买家首先发现弱点，您就不再是从强势中谈判了.

提供者留存：您退出时最大的单一变量

如果您想要一个简短的答案，说明什么会使医疗实践的估值上升或下降，那就是：提供者留存。不是标志。不是家具。不是网站。不是业主在乡村俱乐部的声誉。留在这里的提供者、可以被招募的提供者，以及那些患者关系能够在交易中存活下来的提供者。这几乎是每个医生实践销售中重心所在，尤其是在市场的非常小的一端.

对典型的中下市场集团进行数学计算。假设一个四位医生的专业实践产生了$8.4百万的收入和$1.15百万的调整后EBITDA。一位医生占据了$2.2百万的收入，并且没有绑定的长期雇佣协议。如果那位医生离开，买方模型预测35%的患者流失风险，加上$420,000的招聘、签约和临时覆盖成本。调整后的EBITDA从$1.15百万降至大约$720,000。在6.0倍EBITDA的情况下，价值从$6.9百万降至$4.32百万。这意味着由于在销售过程开始之前没有确定一位提供者的关系，损失了$2.58百万的价值.

同样的逻辑适用于卖方医生。买方并不期望每位创始人都能永远留在公司，但他们绝对会对过渡进行评估。六到十二个月的可见交接、患者沟通、病历过渡和提供者重叠通常能更好地保护价值，而不是模糊地承诺“如有需要会提供帮助”。如果出售的医生希望在交易结束时消失，买方要么会降低报价，要么将资金转入有条件的对价，或者要求对剩余临床团队进行更高的留存经济补偿.

医院和私募股权支持的团体不仅关心医生。他们关心护士执业者、医生助理、首席医疗助理、办公室管理员、编码主管、转诊协调员和收入周期领导者。在一个医生实践中，这些人通常掌握着业务的运营记忆。在前90天内失去账单经理、转诊护士和两名雇佣医生的买家，并没有购买一个稳定的平台。他们购买的是一个修复项目。.

这就是为什么在数据室开放之前，医生雇佣协议、薪酬模型、通知期和限制性契约的可执行性应该得到清理。市场会宽容很多，但它不会宽容可避免的提供者不稳定。如果你的团队有关键合同多年未审查，或者你不确定买家如何看待你的提供者集中风险，, 安排您的保密咨询 在你传播数字之前。这个对话在第一次表示兴趣之前是更便宜的，而不是在第一次重新交易之后。.

斯塔克法和医生销售中的反回扣考虑事项

这是一个糟糕结构将良好经济交易变成昂贵法律纠纷的部分。如果买家实际上因为你的转诊将为其医院、影像中心、实验室或手术业务提供支持而支付高于公平市场价值的费用，那并不是聪明的结构。这是风险。严肃的医疗保健买家知道这一点。成熟的卖家也应该知道这一点。.

CMS的斯塔克法框架禁止医生将指定健康服务推荐给与其有财务关系的实体，除非适用例外情况。对于一次性医生实践销售，最相关的概念通常是42 CFR 411.357(f)中的孤立交易例外。当前规则规定，孤立交易中的补偿必须与公平市场价值一致，不能以考虑推荐的数量或价值的方式确定，并且是在即使没有推荐的情况下也会被商业合理地提供的安排下进行。它还限制了交易双方在交易结束后六个月内的额外交易，除非这些交易符合其他例外情况和不反映推荐的商业合理的交易后调整。.

这很重要，因为卖方通常会同意附带安排，而没有考虑它们将如何被一起看待。雇佣补偿。医疗主任薪酬。呼叫覆盖。医疗办公大楼的租赁条款。设备租赁。共同管理。电子健康记录支持。买方和律师不会孤立地看待这些项目。他们会查看双方之间的总体经济状况，并询问组合包是否仍然符合公平市场价值。.

反回扣法是不同的，在某些方面更为严格。HHS OIG在2024年的常见问题解答中表示，遵守安全港是自愿的，未能满足安全港并不自动使安排变为非法，但满足Stark法案并不自动使您在反回扣法下受到保护。OIG明确表示，一个安排可以符合Stark例外，但仍然违反反回扣法，这取决于事实和意图。这是太多医生卖家在假设医院或平台买家会“处理合规问题”时所忽视的要点。”

实践销售中的常见危险领域并不神秘。购买价格只有在卖方在销售后继续推荐DHS时才有意义。买方仍然需要的空间的高于市场租金。补偿公式悄悄奖励附属服务而非个人生产力。管理费用背后没有可辩护的公平市场价值分析。与下游推荐模式而非合法运营表现挂钩的收益。所有这些都不是理论。这是医疗交易被拖延、重新整理或重新定价的地方。.

对于常见的后期安排，如办公空间租赁、设备租赁、个人服务合同以及电子健康记录（EHR）项目和服务，存在安全港和例外情况，但每种情况都有详细的条件。实用规则很简单：如果你的价格故事的一部分依赖于与买方的后期关系，请尽早寻求医疗保健监管顾问和公平市场价值支持的帮助。更广泛的流程工作仍然适用，但医生实践交易需要另一层纪律。 2026终极卖方指南 still applies, but physician practice deals need another layer of discipline.

附加收入：影像学、实验室、办公室内程序

附加收入可以显著增加价值，但前提是它是盈利的、可转让的，并且符合规定。业主喜欢说，“我们有内部影像学和实验室”，仿佛仅凭这句话就能创造出溢价。实际上并非如此。买方想知道附加收入线是否真正贡献了利润，利用率是否可以辩护，监督和文档是否清晰，付款方合同是否认可该服务，以及当当前医生不再做出每一个决策时，收入是否能够持续。.

Consider a $5.6 million specialty practice with $840,000 of core practice EBITDA and another $260,000 from imaging, lab, and in-office procedures. If all of that ancillary EBITDA is well documented, spread across multiple providers, and consistent with the practice’s clinical model, a buyer valuing the platform at 6.0x could justify about $6.6 million. Now change the facts. Suppose $120,000 of the ancillary EBITDA depends almost entirely on one selling physician’s ordering pattern and another $80,000 looks thin under coding or utilization review. The buyer may only credit $60,000 to $100,000 of that ancillary margin. That alone can wipe out roughly $960,000 to $1.2 million of enterprise value.

Hospitals and PE-backed groups read ancillaries differently. A hospital may value imaging or procedures that fit an existing service-line strategy, but it will be highly sensitive to Stark and compensation interactions. A PE-backed group usually focuses first on margin, throughput, coding discipline, and whether the ancillary line can be replicated across locations. In both cases, the premium comes from transferability, not from the seller’s enthusiasm.

并非所有附加收入都值得相同的倍数。由多位临床医生支持的办公室内程序线，干净的排程，清晰的文档和持久的需求，比起一位创始人每月只进行三天半的利基程序线要有价值得多。实验室和影像学也是如此。买家为系统支付全额费用。他们会对医生特定的习惯进行折扣。.

如果你想捍卫附加价值，准备好展示按服务线的盈利能力、按提供者的利用率、支付者表现、设备正常运行时间、转诊来源和合规支持。如果你无法迅速提供这些，买家会认为该业务线比管理层所声称的要弱。他们往往是正确的。.

电子健康记录、技术架构和运营效率

技术本身并不创造价值，但薄弱的系统不断破坏价值。在医生实践交易中，电子健康记录和收入周期架构并不是后台细节。它们是买方判断管理层是否真正了解业务的证据。如果你的电子健康记录能够在几分钟内生成提供者级别的生产力、按地点的支付者组合、到第三个下一个可用预约的天数、缺席率、按CPT家族的访问计数和转诊泄漏报告，买方就会放松。如果你的团队需要两周和三个电子表格来回答基本的尽职调查问题，买方会认为该操作很脆弱。.

Operational efficiency matters because buyers are pricing not just earnings, but the cost to integrate and improve the practice. A hospital wants to know how painful it will be to move the site into a system workflow. A PE-backed group wants to know whether billing, scheduling, intake, prior authorization, and patient communication can be standardized across a larger platform. Clean dashboards, disciplined templates, and basic KPI visibility support value because they reduce post-close friction.

There is also a regulatory angle. Current Stark and AKS rules include exceptions and safe-harbor protection for certain electronic health record items and services, but they are not free-for-all subsidies. The Stark EHR exception requires interoperable software, a written agreement, and a physician contribution equal to 15% of the donor’s cost. AKS safe-harbor protection around EHR and cybersecurity support has similar structure and documentation requirements. If part of your integration story depends on a buyer helping fund or replace your tech, that support must be papered properly.

Cybersecurity and data governance now matter more than many independent groups still realize. A buyer who sees poor user-permission controls, weak documentation of vendor oversight, or no coherent incident-response process is not just worried about IT. They are worried about reputational risk, post-close cleanup cost, and management discipline. In a professional practice sale, operational sloppiness is never confined to one department.

The practical takeaway is simple. Before the sale process starts, know which reports your system can produce, clean up the ones that matter, and test whether the team can deliver them under time pressure. That work is boring. It is also profitable.

Real Estate and Medical Office Building Considerations

Medical real estate is one of the easiest places for sellers to confuse asset value with operating value. The building may be important, but the practice should still be priced as a practice. If you own the medical office building and charge yourself below-market rent, buyers will normalize rent upward before they value EBITDA. If you charge yourself above-market rent because you want more cash flow in the real estate entity, buyers will normalize it downward. Either way, the market is going to reset the number.

Take a simple example. Your practice occupies 8,000 square feet and currently pays a related-party rent equivalent to $15 per square foot. The market for comparable medical space says $24 per square foot is more realistic. That is a $72,000 annual EBITDA adjustment. At 5.5x EBITDA, the value impact is roughly $396,000. That change has nothing to do with patient care and everything to do with whether your numbers reflect market economics.

Lease structure matters too. Buyers want term, renewal options, assignment rights, clear responsibility for CAM and capital items, and rent that can be defended as fair market value. That is not only economics. It is also compliance. The Stark and AKS rules for office-space leases and equipment rentals both require written agreements, a term of at least one year, compensation set in advance, fair-market-value economics, and no referral-based pricing. If the practice sale is followed by a leaseback or continued occupancy arrangement, sloppy documents can create immediate diligence drag.

Rate conditions also matter in 2026. Even though this article is about selling to groups, the broader buyer universe still feels the lending market. A $2.7 million 10-year note at 9.75% carries annual debt service of about $423,696. At 1.25x debt-service coverage, that implies about $529,620 of dependable cash flow. If the practice and real estate are bundled into a structure that blows past what the next-best buyer could reasonably finance, you may have narrowed your own market without realizing it.

For many Indiana physician sellers, the best answer is to separate the economics clearly. Value the practice on normalized operating earnings. Value the building on market rent and real estate fundamentals. Then decide whether the best buyer needs both, only the practice, or the practice with a long-term lease. Blurring the categories creates financing problems that sellers often mistake for valuation problems.

Indiana Medicaid, IU Health, and Ascension Buyer Dynamics

This is where Indiana stops looking like a generic healthcare market. State Medicaid mechanics, local system footprints, and county-level demand all shape what buyers will pay and how they structure the deal. If you ignore those variables, you are not really pricing an Indiana medical practice. You are pricing a fantasy practice in a generic spreadsheet.

Start with Indiana Medicaid. The state’s provider-enrollment guidance is clear that a change of ownership is treated as a new enrollment rather than a simple profile update. The IHCP says business-profile changes generally must be reported within 10 business days, but a true CHOW requires a fresh enrollment package, supporting documentation, and proof of the ownership transaction such as a purchase agreement or bill of sale. Revalidation intervals cannot exceed five years for most providers, and the state says providers receive 60-day and 30-day notices before revalidation deadlines. If an application fee applies, Indiana says the 2026 amount is $750 per service location. That may not be a big check in a $5 million deal, but it is exactly the kind of detail that can slow reimbursement if nobody owns it.

Now look at the system side. IU Health describes itself as the largest network of physicians in Indiana and says it operates 15 hospitals with a unified medical group, about 39,000 team members, and more than 600 sites of care. A system that large does not evaluate your practice like a solo buyer would. It is asking where you fit in regional coverage, which service lines you strengthen, how your providers align with the system, and whether the revenue can be integrated without creating a compliance headache.

Ascension St. Vincent is just as relevant to the buyer map. Ascension’s Indiana pages say the system operates 19 hospitals and two children’s hospitals in the state, and its 2024 Indiana implementation-strategy documents say Ascension St. Vincent employs more than 13,000 associates statewide. That matters because the St. Vincent footprint spans Indianapolis, the north suburbs, central Indiana, and the Evansville area. Sellers in those corridors are often not negotiating against an abstract “hospital market.” They are negotiating inside a real strategic footprint.

The county data explains why the same specialty can price differently in different Indiana markets. Hamilton County offers affluent suburban growth and strong employer density. Marion County offers scale and a massive healthcare ecosystem. Allen County gives buyers a Fort Wayne regional-hub platform with more than $6.22 billion in health care receipts. Vanderburgh County remains strategically important because it anchors a southern Indiana market with more than $3.01 billion in health care receipts and strong system presence. Buyers build recruiting, access, and growth assumptions directly from those realities.

PE-backed groups read the map differently, but they read it. They like Indianapolis and the north-suburban corridor because add-on density is easier to create. They like Fort Wayne because Allen County supports a regional-hub story without Indianapolis competition levels. They like Evansville and other secondary markets when a platform can gain coverage without paying top-tier metro pricing. What they do not like is a practice that depends on one physician in a county where replacement recruiting is a three-alarm problem.

That is the practical Indiana picture as of April 11, 2026. Medicaid-heavy practices need enrollment and managed-care discipline. Practices in major system corridors need to understand local strategic demand, not just national roll-up chatter. And every physician owner considering a sale to a group needs to know which local buyer logic applies before the process starts.

Exit Playbook: 18 Months of Prep That Protects Value

Eighteen months is enough time to improve value if the fundamentals are sound. It is not enough time to fake a transferable business. The physicians who get paid best are usually the ones who use that window to remove buyer objections before the market sees them.

Start with the numbers, then move to transferability, then move to structure. That order matters. If you begin with marketing and skip the cleanup, the buyer will find the weak spots for you. The better sequence is to get the financial picture right, document the provider and ancillary story, clean the compliance file, and then decide which buyer audience you are really targeting.

• 18 months out: Recast the financials. Separate owner-specific expenses, normalize physician compensation, and build monthly reporting that ties to tax returns and practice-management data.
• 16 months out: Analyze payer mix by provider, location, and service line. Know exactly where margin comes from and where denials or underpayments live.
• 15 months out: Review provider agreements, compensation plans, notice periods, and restrictive covenants. If provider retention is weak, fix it before the market sees it.
• 13 months out: Pull A/R aging, denial trends, charge lag, and collection-rate reporting. Clean up stale balances and document what is truly collectible.
• 12 months out: Audit ancillaries. Break out revenue, margin, equipment, supervision requirements, payor performance, and provider dependence by line.
• 10 months out: Resolve the real-estate story. Decide whether the building is part of the exit, held under lease, or sold separately, and paper market economics accordingly.
• 9 months out: Test the EHR and revenue-cycle reporting package. If the data room cannot answer obvious buyer questions fast, fix the workflow now.
• 7 months out: Clean licensure, credentialing, and Indiana Medicaid files. CHOW timing, revalidation, and managed-care credentialing delays should not be a surprise after LOI.
• 5 months out: Build the transition plan for the seller and key providers. Decide what post-close employment or consulting support is realistic and defensible.
• 3 months out: Pressure-test net proceeds, not just enterprise value. Run debt payoff, taxes, working capital, rollover, and the Double Lehman fee math before you set your walk-away number.

If you want a broader process map beyond healthcare-specific issues, the 2026 ultimate seller guide is worth reading alongside this article. But physician practices live and die on details that generic exit planning misses: provider transferability, payer discipline, and compliance structure. That is where price gets defended or lost.